Please use this link to access this publication. Abstract As cannabis use is rising and federal restrictions are easing, it is important to recognize its potential adverse cardiovascular effects for…
Condition: Cannabis Use Disorder
Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis
Abstract Background: Tobacco use disorder (TUD) adversely impacts older patients with established cardiovascular disease (CVD) risk. However, CVD risk in chronic habitual cannabis users without the confounding impact of TUD…
Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning
Please use this link to access this publication. Key Points Question What is the association of state-level medical and recreational cannabis laws with cannabis use disorder (CUD) and cannabis poisonings in…
Adverse Impact of Cannabis on Human Health
ABSTRACT Cannabis, the most commonly used recreational drug, is illicit in many areas of the world. With increasing decriminalization and legalization, cannabis use is increasing in the United States and…
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders
Please use this link to access this publication. Abstract Objective: To estimate the prevalence of ADHD and determine an effective screening test for ADHD in a population-seeking treatment for cannabis use…
Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership
Abstract Background: Evidence for long-term effectiveness of commercial cannabis products used to treat medical symptoms is inconsistent, despite increasingly widespread use. Objective: To prospectively evaluate the effects of using cannabis on self-reported…
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
Abstract Cannabis is the most frequently used illicit drug in the United States with more than 45 million users of whom one-third suffer from a cannabis use disorder (CUD). Despite…
A large-scale genome-wide association study meta-analysis of cannabis use disorder
Summary Background Variation in liability to cannabis use disorder has a strong genetic component (estimated twin and family heritability about 50–70%) and is associated with negative outcomes, including increased risk…
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
Abstract Importance: There are no medications approved for treating cannabis dependence or withdrawal. The cannabis extract nabiximols (Sativex), developed as a multiple sclerosis treatment, offers a potential agonist medication for cannabis…
Treatment of Cannabis Use Disorders: A Review of the Literature
Please use this link to access this publication. Abstract Cannabis is the most widely used illicit drug in the United States. Despite the fact that there are large numbers of…